Prostate Cancer Research (Part 2)

Join us for another engaging episode of PROSTATE CANCER: REAL TALK, where hosts El and Shay continue their conversation with Dr. Natalie Reizine, a distinguished medical oncologist and researcher at UI Health and the University of Illinois Cancer Center.

Building on our previous discussion about glycyrrhizin, this episode dives deeper into the latest advancements in prostate cancer research. Dr. Reizine discusses how cutting-edge research shapes personalized prostate cancer treatment strategies.

Explore the role of genetic profiling in optimizing treatment effectiveness and reducing side effects, highlighting the progress being made in the fight against this disease. Tune in to learn more about the pioneering work being done in prostate cancer research and how it's paving the way for more effective and targeted therapies.


CONTACT INFORMATION:

If you are interested in the trial, contact the UI Health Clinical Trials office at 312-355-5112 or cancertrials@uic.edu

If you are interested in an appointment at UI Health, please contact 866-600-2273 (CARE) or https://hospital.uillinois.edu/make-an-appointment


Please type your comments and questions below.

(To submit audio/video questions, take a look at our Facebook!)

Previous
Previous

Prostate Cancer Support Through Encouragement, Empathy and Hope

Next
Next

Can Glycyrrhizin (Licorice Root) Help Fight Prostate Cancer? (Part 1)